(Reuters) -Biogen Inc on Thursday said the U.S. Food and Drug Administration has narrowed use of its Alzheimer’s drug after the agency drew sharp criticism…
Home »
Big Biogen boost on Alzheimer's news could win back biotech investors
NEW YORK (Reuters) – The approval by U.S. regulators on Monday of a Biogen Inc drug to treat Alzheimer’s disease could reinvigorate investor interest more…
FDA grants expedited review to Biogen's Alzheimer's drug
(Reuters) – Biogen Inc and Japan’s Eisai Co Ltd said on Friday the U.S. Food and Drug Administration has granted an expedited review for the…
Biogen raises full-year profit view, quarter boosted by Tecfidera demand
(Reuters) – Drugmaker Biogen Inc (BIIB.O) beat analysts’ estimates for quarterly profit on Wednesday on better-than-expected sales of its multiple sclerosis treatment Tecfidera, and boosted…